Same Indication

Ipilimumab vs Simvastatin

Ipilimumab vs Simvastatin: Overview

This comparison examines the pharmacological differences between Ipilimumab and Simvastatin.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Simvastatin — 2 hours.

Chemical Properties

Molecular Formula: Simvastatin — C25H38O5.

Molecular Weight: Simvastatin — 418.5700 g/mol.

Type: Ipilimumab — Antibody; Simvastatin — Small molecule.